IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 25 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,664,005 | -5.1% | 50,071,000 | -0.3% | 1.81% | +1.6% |
| Q2 2023 | $51,296,182 | +12.7% | 50,246,000 | +10.6% | 1.78% | +16.9% |
| Q1 2023 | $45,517,071 | +12.0% | 45,423,000 | +21.9% | 1.52% | +16.3% |
| Q4 2022 | $40,623,600 | -0.6% | 37,248,000 | -7.4% | 1.31% | -4.5% |
| Q3 2022 | $40,854,000 | -6.0% | 40,225,000 | 0.0% | 1.37% | +2.3% |
| Q2 2022 | $43,443,000 | -13.7% | 40,225,000 | -5.9% | 1.34% | -10.5% |
| Q1 2022 | $50,351,000 | +8.9% | 42,725,000 | +4.9% | 1.50% | -12.9% |
| Q4 2021 | $46,223,000 | -5.2% | 40,725,000 | 0.0% | 1.72% | -10.6% |
| Q3 2021 | $48,765,000 | +8.7% | 40,725,000 | +8.0% | 1.92% | +3.2% |
| Q2 2021 | $44,872,000 | +12.9% | 37,725,000 | +7.1% | 1.86% | -4.2% |
| Q1 2021 | $39,760,000 | -2.1% | 35,225,000 | -2.8% | 1.94% | +38.2% |
| Q4 2020 | $40,606,000 | +18.9% | 36,225,000 | +2.8% | 1.41% | +28.8% |
| Q3 2020 | $34,154,000 | – | 35,225,000 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAMDEN ASSET MANAGEMENT L P /CA | 40,225,000 | $40,854,000 | 1.37% |
| Wellesley Asset Management | 15,287 | $15,583,000 | 1.10% |
| SSI INVESTMENT MANAGEMENT LLC | 4,671,000 | $4,738,000 | 0.32% |
| WOLVERINE ASSET MANAGEMENT LLC | 21,495,000 | $21,916,000 | 0.24% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,206,000 | $3,255,000 | 0.18% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 22,674,000 | $23,142,000 | 0.14% |
| AQR Arbitrage LLC | 4,100,000 | $4,185,000 | 0.09% |
| Polar Asset Management Partners Inc. | 7,000,000 | $7,164,000 | 0.09% |
| Calamos Advisors LLC | 9,500,000 | $9,722,000 | 0.04% |
| PUTNAM INVESTMENTS LLC | 7,105,000 | $7,216,000 | 0.01% |